Association between C-reactive protein (CRP) with depression symptom severity and specific depressive symptoms in major depression

Brain, Behavior, and Immunity

Volumn 62, Issue , 2017, Pages 344-350

  Köhler Forsberg, Ole ^a,b   Buttenschøn, Henriette N ^b,c   Tansey, Katherine E ^e   Maier, Wolfgang ^f   Hauser, Joanna ^g   Dernovsek, Mojca Zvezdana ^h   Henigsberg, Neven ⁱ   Souery, Daniel ^j   Farmer, Anne ^e   Rietschel, Marcella ^l   McGuffin, Peter ^e   Aitchison, Katherine J ^e,k   Uher, Rudolf ^d   Mors, Ole ^a,b  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b Lundbeck Foundation Initiative for Integrative Psychiatric Research   (Denmark)

^c AARHUS UNIVERSITY   (Denmark)

^d DALHOUSIE UNIVERSITY   (Canada)

^e MEDICAL RESEARCH COUNCIL   (United Kingdom)

^f UNIVERSITY OF BONN   (Germany)

^g POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^h University Psychiatric Clinic   (Slovenia)

ⁱ UNIVERSITY OF ZAGREB   (Croatia)

^j UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^k UNIVERSITY OF ALBERTA   (Canada)

^l UNIVERSITY OF HEIDELBERG   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; C REACTIVE PROTEIN; PSYCHOTROPIC AGENT; BIOLOGICAL MARKER;

ADULT; AGE DISTRIBUTION; ARTICLE; BODY MASS; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HAMILTON DEPRESSION RATING SCALE; HUMAN; IMMUNOMODULATION; INFLAMMATION; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MONTGOMERY ASBERG DEPRESSION RATING SCALE; MOOD DISORDER; PERSONALIZED MEDICINE; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; SEX DIFFERENCE; SMOKING HABIT; SOCIAL BEHAVIOR; SUICIDAL BEHAVIOR; SYMPTOMATOLOGY; BLOOD; DEPRESSION; MIDDLE AGED; PSYCHOLOGICAL RATING SCALE; RISK FACTOR; SEVERITY OF ILLNESS INDEX; SEX FACTOR;

ADULT; BIOMARKERS; C-REACTIVE PROTEIN; DEPRESSION; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SEX FACTORS;

EID: 85014838761     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2017.02.020     Document Type: Article

References (41)

1. Angele, M.K., Pratschke, S., Hubbard, W.J., Chaudry, I.H., Gender differences in sepsis: cardiovascular and immunological aspects. Virulence 5:1 (2014), 12–19.
2. Au, B., Smith, K.J., Gariepy, G., Schmitz, N., The longitudinal associations between C-reactive protein and depressive symptoms: evidence from the english longitudinal study of ageing (ELSA). Int. J. Geriatr. Psychiatry 30:9 (2015), 976–984.
3. Beck, A.T., Ward, C.H., Mendelson, M., Mock, J., Erbaugh, J., An inventory for measuring depression. Archiv. Gener. Psychiat. 4 (1961), 561–571.
4. Breen, E.C., Reynolds, S.M., Cox, C., Jacobson, L.P., Magpantay, L., Mulder, C.B., Dibben, O., Margolick, J.B., Bream, J.H., Sambrano, E., Martinez-Maza, O., Sinclair, E., Borrow, P., Landay, A.L., Rinaldo, C.R., Norris, P.J., Multisite comparison of high-sensitivity multiplex cytokine assays. Clin. Vaccine Immunol. CVI 18:8 (2011), 1229–1242.
5. Case, S.M., Stewart, J.C., Race/ethnicity moderates the relationship between depressive symptom severity and C-reactive protein: 2005–2010 NHANES data. Brain Behav. Immun. 41 (2014), 101–108.
6. Danner, M., Kasl, S.V., Abramson, J.L., Vaccarino, V., Association between depression and elevated C-reactive protein. Psychosom. Med. 65:3 (2003), 347–356.
7. Derry, H.M., Padin, A.C., Kuo, J.L., Hughes, S., Kiecolt-Glaser, J.K., Sex differences in depression: does inflammation play a role?. Curr. Psychiatry Rep., 17(10), 2015 pp. 78-015-0618-5.
8. Dowlati, Y., Herrmann, N., Swardfager, W., Liu, H., Sham, L., Reim, E.K., Lanctot, K.L., A meta-analysis of cytokines in major depression. Biol. Psychiatry 67:5 (2010), 446–457.
9. Elovainio, M., Aalto, A.M., Kivimaki, M., Pirkola, S., Sundvall, J., Lonnqvist, J., Reunanen, A., Depression and C-reactive protein: population-based Health 2000 Study. Psychosom. Med. 71:4 (2009), 423–430.
10. Figueroa-Vega, N., Moreno-Frias, C., Malacara, J.M., Alterations in adhesion molecules, pro-inflammatory cytokines and cell-derived microparticles contribute to intima-media thickness and symptoms in postmenopausal women. PLoS One, 10(5), 2015, e0120990.
11. Ford, D.E., Erlinger, T.P., Depression and C-reactive protein in US adults: data from the third national health and nutrition examination survey. Archiv. Internal Med. 164:9 (2004), 1010–1014.
12. Gaskins, A.J., Wilchesky, M., Mumford, S.L., Whitcomb, B.W., Browne, R.W., Wactawski-Wende, J., Perkins, N.J., Schisterman, E.F., Endogenous reproductive hormones and C-reactive protein across the menstrual cycle: the biocycle study. Am. J. Epidemiol. 175:5 (2012), 423–431.
13. Hafner, S., Baghai, T.C., Eser, D., Schule, C., Rupprecht, R., Bondy, B., Bedarida, G., von Schacky, C., C-reactive protein is associated with polymorphisms of the angiotensin-converting enzyme gene in major depressed patients. J. Psychiatr. Res. 42:2 (2008), 163–165.
14. Hafner, S., Emeny, R.T., Lacruz, M.E., Baumert, J., Herder, C., Koenig, W., Thorand, B., Ladwig, K.H., KORA Study Investigators. Association between social isolation and inflammatory markers in depressed and non-depressed individuals: results from the MONICA/KORA study. Brain Behav. Immun. 25:8 (2011), 1701–1707.
15. Hamilton, M., A rating scale for depression. J. Neurol. Neurosurg. Psychiatry 23 (1960), 56–62.
16. Herder, C., Furstos, J.F., Nowotny, B., Begun, A., Strassburger, K., Mussig, K., Szendroedi, J., Icks, A., Roden, M., GDS Group, Associations between inflammation-related biomarkers and depressive symptoms in individuals with recently diagnosed type 1 and type 2 diabetes. Brain Behav. Immun., 2016.
17. Hope, S., Ueland, T., Steen, N.E., Dieset, I., Lorentzen, S., Berg, A.O., Agartz, I., Aukrust, P., Andreassen, O.A., Interleukin 1 receptor antagonist and soluble tumor necrosis factor receptor 1 are associated with general severity and psychotic symptoms in schizophrenia and bipolar disorder. Schizophrenia Res. 145:1–3 (2013), 36–42.
18. Howren, M.B., Lamkin, D.M., Suls, J., Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom. Med. 71:2 (2009), 171–186.
19. Jokela, M., Virtanen, M., Batty, G.D., Kivimaki, M., Inflammation and specific symptoms of depression. JAMA Psychiatry, 2015, 1–2.
20. Khandaker, G.M., Pearson, R.M., Zammit, S., Lewis, G., Jones, P.B., Association of serum interleukin 6 and C-reactive protein in childhood with depression and psychosis in young adult life: a population-based longitudinal study. JAMA Psychiatry, 2014.
21. Kohler, O., Benros, M.E., Nordentoft, M., Farkouh, M.E., Iyengar, R.L., Mors, O., Krogh, J., Effect of anti-inflammatory treatment on depression, depressive symptoms, and adverse effects: a systematic review and meta-analysis of randomized clinical trials. JAMA Psychiatry 71:12 (2014), 1381–1391.
22. Kohler, O., Krogh, J., Mors, O., Benros, M.E., Inflammation in depression and the potential for anti-inflammatory treatment. Curr. Neuropharmacol. 14:7 (2016), 732–742.
23. Kohler, O., Sylvia, L.G., Bowden, C.L., Calabrese, J.R., Thase, M., Shelton, R.C., Mcinnis, M., Tohen, M., Kocsis, J.H., Ketter, T.A., Friedman, E.S., Deckersbach, T., Ostacher, M.J., Iosifescu, D.V., Mcelroy, S., Nierenberg, A.A., White blood cell count correlates with mood symptom severity and specific mood symptoms in bipolar disorder. Aust. N. Z. J. Psychiatry, 2016.
24. Krogh, J., Benros, M.E., Jorgensen, M.B., Vesterager, L., Elfving, B., Nordentoft, M., The association between depressive symptoms, cognitive function, and inflammation in major depression. Brain Behav. Immun. 35 (2014), 70–76.
25. Moieni, M., Irwin, M.R., Jevtic, I., Olmstead, R., Breen, E.C., Eisenberger, N.I., Sex differences in depressive and socioemotional responses to an inflammatory challenge: implications for sex differences in depression. Neuropsychopharmacology 40:7 (2015), 1709–1716.
26. Montgomery, S.A., Asberg, M., A new depression scale designed to be sensitive to change. Br. J. Psychiatry 134 (1979), 382–389.
27. Pearlman, D.M., Brown, J.R., Mackenzie, T.A., Hernandez JR, F., Najjar, S., Blood levels of S-100 calcium-binding protein B, high-sensitivity C-reactive protein, and interleukin-6 for changes in depressive symptom severity after coronary artery bypass grafting: prospective cohort nested within a randomized, controlled trial. PLoS One, 9(10), 2014, e111110.
28. Prins, B.P., Abbasi, A., Wong, A., Vaez, A., Nolte, I., Franceschini, N., Stuart, P.E., Guterriez Achury, J., Mistry, V., Bradfield, J.P., Valdes, A.M., Bras, J., Shatunov, A., Page Consortium, International Stroke Genetics Consortium, Systemic Sclerosis Consortium, Treat Oa Consortium, Diagram Consortium, Cardiogramplusc4d Consortium, ALS Consortium, International Parkinson's Disease Genomics Consortium, Autism Spectrum Disorder Working Group of the Psychiatric Genomics Consortium, CKDGEN Consortium, Gerad1 Consortium, International Consortium for Blood Pressure, Schizophrenia Working Group of the Psychiatric Genomics Consortium, Inflammation Working Group of the Charge Consortium, Lu, C., Han, B., Raychaudhuri, S., Bevan, S., Mayes, M.D., Tsoi, L.C., Evangelou, E., Nair, R.P., Grant, S.F., Polychronakos, C., Radstake, T.R., Van Heel, D.A., Dunstan, M.L., Wood, N.W., Al-Chalabi, A., Dehghan, A., Hakonarson, H., Markus, H.S., Elder, J.T., Knight, J., Arking, D.E., Spector, T.D., Koeleman, B.P., Van Duijn, C.M., Martin, J., Morris, A.P., Weersma, R.K., Wijmenga, C., Munroe, P.B., Perry, J.R., Pouget, J.G., Jamshidi, Y., Snieder, H., Alizadeh, B.Z., Investigating the causal relationship of C-reactive protein with 32 complex somatic and psychiatric outcomes: a large-scale cross-consortium Mendelian randomization study. PLoS Med., 13(6), 2016, e1001976.
29. Raison, C.L., Miller, A.H., Depression in cancer: new developments regarding diagnosis and treatment. Biol. Psychiatry 54:3 (2003), 283–294.
30. Raison, C.L., Rutherford, R.E., Woolwine, B.J., Shuo, C., Schettler, P., Drake, D.F., Haroon, E., Miller, A.H., A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers. JAMA Psychiatry (Chicago, Ill.) 70:1 (2013), 31–41.
31. Saper, C.B., Romanovsky, A.A., Scammell, T.E., Neural circuitry engaged by prostaglandins during the sickness syndrome. Nat. Neurosci. 15:8 (2012), 1088–1095.
32. Song, B.M., Lee, J.M., Choi, W., Youm, Y., Chu, S.H., Park, Y.R., Kim, H.C., Association between C reactive protein level and depressive symptoms in an elderly Korean population: Korean Social Life, Health and Aging Project. BMJ Open, 5(2), 2015 pp. e006429-2014-006429.
33. Strawbridge, R., Arnone, D., Danese, A., Papadopoulos, A., Herane Vives, A., Cleare, A.J., Inflammation and clinical response to treatment in depression: a meta-analysis. Eur. Neuropsychopharmacol. 25:10 (2015), 1532–1543.
34. Suarez, E.C., Sundy, J.S., Erkanli, A., Depressogenic vulnerability and gender-specific patterns of neuro-immune dysregulation: what the ratio of cortisol to C-reactive protein can tell us about loss of normal regulatory control. Brain Behav. Immun. 44 (2015), 137–147.
35. Tonstad, S., Cowan, J.L., C-reactive protein as a predictor of disease in smokers and former smokers: a review. Int. J Clin. Pract. 63:11 (2009), 1634–1641.
36. Uher, R., Farmer, A., Maier, W., Rietschel, M., Hauser, J., Marusic, A., Mors, O., Elkin, A., Williamson, R.J., Schmael, C., Henigsberg, N., Perez, J., Mendlewicz, J., Janzing, J.G., Zobel, A., Skibinska, M., Kozel, D., Stamp, A.S., Bajs, M., Placentino, A., Barreto, M., McGuffin, P., Aitchison, K.J., Measuring depression: comparison and integration of three scales in the GENDEP study. Psychol. Med. 38:2 (2008), 289–300.
37. Uher, R., Maier, W., Hauser, J., Marusic, A., Schmael, C., Mors, O., Henigsberg, N., Souery, D., Placentino, A., Rietschel, M., Zobel, A., Dmitrzak-Weglarz, M., Petrovic, A., Jorgensen, L., Kalember, P., Giovannini, C., Barreto, M., Elkin, A., Landau, S., Farmer, A., Aitchison, K.J., McGuffin, P., Differential efficacy of escitalopram and nortriptyline on dimensional measures of depression. Br. J. Psychiatry 194:3 (2009), 252–259.
38. Uher, R., Tansey, K.E., Dew, T., Maier, W., Mors, O., Hauser, J., Dernovsek, M.Z., Henigsberg, N., Souery, D., Farmer, A., McGuffin, P., An inflammatory biomarker as a differential predictor of outcome of depression treatment with escitalopram and nortriptyline. Am. J. Psychiatry 171:12 (2014), 1278–1286.
39. Vetter, M.L., Wadden, T.A., Vinnard, C., Moore, R.H., Khan, Z., Volger, S., Sarwer, D.B., Faulconbridge, L.F., Power-up Research Group, Gender differences in the relationship between symptoms of depression and high-sensitivity CRP. Int. J. Obesity 37:Suppl. 1 (2005), S38–S43.
40. Wing, J., Sartorius, N., Üstun, T., (eds.) WHO Diagnosis and Clinical Measurement in Psychiatry. A Reference Manual for SCAN, 1998, Cambridge University Press, Cambridge.
41. Wium-Andersen, M.K., Orsted, D.D., Nielsen, S.F., Nordestgaard, B.G., Elevated C-reactive protein levels, psychological distress, and depression in 73, 131 individuals. JAMA Psychiatry (Chicago, Ill.) 70:2 (2013), 176–184.